Postmenopausal Osteoporosis: Causes & Treatment
Postmenopausal osteoporosis is a bone-thinning disease caused by estrogen deficiency after menopause, significantly increasing the risk of fractures.
Things worth knowing about "Postmenopausal osteoporosis"
Postmenopausal osteoporosis is a bone-thinning disease caused by estrogen deficiency after menopause, significantly increasing the risk of fractures.
What is postmenopausal osteoporosis?
Postmenopausal osteoporosis is a skeletal disease in which bone density and bone quality decline after menopause – the permanent cessation of menstrual periods. The primary cause is a drop in estrogen, a female sex hormone that normally protects bone tissue. Without adequate estrogen, bone is broken down faster than it is rebuilt, leaving the skeleton fragile and prone to fractures.
Osteoporosis is often called a "silent disease" because it typically develops without pain and is only discovered when a bone breaks. The most common fracture sites are the spine, hip, and wrist.
Causes
The key trigger of postmenopausal osteoporosis is the sharp decline in estrogen levels after the last menstrual period. Estrogen normally suppresses the activity of osteoclasts (bone-resorbing cells). When this protective effect is lost, bone resorption accelerates.
Additional risk factors include:
- Early menopause (before age 45)
- Family history of osteoporosis or fractures
- Calcium and vitamin D deficiency
- Physical inactivity
- Smoking and excessive alcohol consumption
- Long-term use of corticosteroids
- Low body weight
Symptoms
In the early stages, postmenopausal osteoporosis causes no symptoms. Over time, the following signs may appear:
- Back pain due to vertebral fractures
- Loss of height and a stooped posture (kyphosis)
- Bone fractures from minimal trauma (e.g., a low-level fall)
- Sudden, severe back pain indicating a vertebral compression fracture
Diagnosis
The gold standard for diagnosis is bone density measurement by DXA scanning (Dual-Energy X-ray Absorptiometry). It produces a T-score:
- T-score ≥ -1.0: normal
- T-score between -1.0 and -2.5: osteopenia (early bone loss)
- T-score ≤ -2.5: osteoporosis
Blood tests (e.g., calcium, vitamin D, bone turnover markers) and X-ray imaging may complement the diagnosis.
Treatment
General measures
Foundation therapy for all patients includes:
- Calcium (1000–1200 mg/day) and vitamin D (800–1000 IU/day) supplementation
- Regular physical activity, especially weight-bearing and balance exercises
- Fall prevention strategies in daily life
- Avoiding smoking and excessive alcohol intake
Pharmacological therapy
When fracture risk is elevated, several medications are available:
- Bisphosphonates (e.g., alendronate, risedronate): inhibit bone resorption; first-line treatment
- Denosumab: a monoclonal antibody that blocks osteoclast activity
- Raloxifene: a selective estrogen receptor modulator (SERM)
- Teriparatide and romosozumab: bone-building agents for severe osteoporosis
- Hormone replacement therapy (HRT): may be considered in younger postmenopausal women after careful benefit-risk assessment
Prevention
Building optimal bone mass during younger years through adequate calcium, vitamin D, and physical activity is the best long-term strategy. After menopause, early medical evaluation is recommended to detect and treat osteoporosis before fractures occur.
References
- World Health Organization (WHO): Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. WHO Technical Report Series 843, Geneva, 1994.
- Kanis JA et al. on behalf of the Scientific Advisory Board of ESCEO: European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporosis International, 2019;30(1):3–44.
- National Osteoporosis Foundation (NOF): Clinician's Guide to Prevention and Treatment of Osteoporosis. Washington DC, 2022.
Most purchased products
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®The latest entries
3 Posts in this encyclopedia categoryGaleazzi fracture
Height loss with age
Most read entries
3 Posts in this encyclopedia categoryMagnesiumcarbonat
Calorie content
Cologne list
Related search terms: Postmenopausal osteoporosis